CLINICAL_TRIALS trial_result · 2023-01-13

Clinical Trial Update: Study of OTO-104 in Subjects With Unilateral Meniere's Disease [Phase 3]

Phase 3 trial of OTO-104 in unilateral Meniere's disease was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Otonomy, Inc. | Conditions: Meniere's Disease | Phase 3 | Status: TERMINATED | Results posted: 2023-01-13